Cipro (Ciprofloxacin) 500 mg (Cipro 500 mg) and Sotalol: interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Additive QT prolongation increases concern about torsades de pointes and serious ventricular arrhythmia.
Clinical significance and safety
Cipro (Ciprofloxacin) 500 mg and Sotalol: Additive QT prolongation increases concern about torsades de pointes and serious ventricular arrhythmia. Heart disease, a slow pulse and low potassium or magnesium can increase concern. A clinician determines whether ECG or electrolyte checks are needed. Fainting or new irregular palpitations require urgent assessment.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.